VanDuyn Amy Beth
Known title: SVP, Human ResourcesCIK: 0001776863
Associated companies
Transaction History
| PHR | ▼ Sell | Tax Withholding | 2,876 | $30K | 9/18/2026 | View on chart |
| PHR | ▲ Buy | Grant | 6,490 | $0 | 9/14/2026 | View on chart |
| PHR | ▲ Buy | Grant | 88,000 | $0 | 9/1/2026 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 9,193 | $84K | 4/9/2026 | View on chart |
| PHR | ▲ Buy | Grant | 20,751 | — | 4/6/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 2,202 | $36K | 1/16/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 687 | $11K | 1/15/2026 | View on chart |
| PHR | ▼ Sell | Open Market | 2,602 | $44K | 1/8/2026 | View on chart |
| PHR | ▲ Buy | Option Exercise | 18,000 | $85K | 12/19/2025 | View on chart |
| PHR | ▲ Buy | Grant | 33,000 | $0 | 12/5/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 639 | $14K | 10/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,762 | $41K | 9/16/2025 | View on chart |
| PHR | ▲ Buy | Grant | 3,634 | — | 9/11/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 18,573 | $564K | 8/25/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 640 | $17K | 7/17/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 624 | $15K | 4/16/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,036 | $24K | 4/8/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 659 | $16K | 4/8/2025 | View on chart |
| PHR | ▲ Buy | Grant | 3,752 | — | 4/4/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,049 | $30K | 1/27/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 2,426 | $66K | 1/27/2025 | View on chart |
| PHR | ▲ Buy | Grant | 7,900 | $0 | 1/23/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 4,720 | $129K | 1/21/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 604 | $16K | 1/15/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 1,311 | $35K | 1/6/2025 | View on chart |
| PHR | ▲ Buy | Grant | 23,474 | $0 | 1/2/2025 | View on chart |
| PHR | ▼ Sell | Open Market | 25,447 | $533K | 12/3/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 624 | $13K | 10/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 737 | $17K | 9/10/2024 | View on chart |
| PHR | ▲ Buy | Grant | 1,642 | — | 9/6/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 374 | $9K | 7/16/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 685 | $16K | 4/15/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 3,768 | $88K | 4/9/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 3,320 | $75K | 4/8/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 34 | $783 | 4/8/2024 | View on chart |
| PHR | ▲ Buy | Grant | 7,122 | — | 4/5/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 10,213 | $246K | 1/17/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 738 | $18K | 1/16/2024 | View on chart |
| PHR | ▲ Buy | Grant | 12,500 | $0 | 1/2/2024 | View on chart |
| PHR | ▼ Sell | Open Market | 665 | $11K | 10/16/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 2,000 | $40K | 9/14/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 1,753 | $36K | 9/13/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 73 | $2K | 9/13/2023 | View on chart |
| PHR | ▲ Buy | Grant | 3,826 | — | 9/12/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 624 | $21K | 7/14/2023 | View on chart |
| PHR | ▲ Buy | Option Exercise | 21,387 | $18K | 4/17/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 570 | $18K | 4/17/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 623 | $20K | 4/14/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 2,196 | $66K | 4/10/2023 | View on chart |
| PHR | ▲ Buy | Grant | 4,956 | — | 4/10/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 2,678 | $82K | 4/3/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 300 | $10K | 4/3/2023 | View on chart |
| PHR | ▼ Sell | Open Market | 300 | $12K | 2/2/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 1,008 | $35K | 1/17/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 1,126 | $40K | 1/15/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 4,226 | $150K | 1/15/2023 | View on chart |
| PHR | ▲ Buy | Grant | 19,768 | $0 | 1/15/2023 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 698 | $25K | 1/14/2023 | View on chart |
| PHR | ▲ Buy | Option Exercise | 15,000 | $13K | 12/20/2022 | View on chart |
| PHR | ▼ Sell | Open Market | 378 | $13K | 12/20/2022 | View on chart |
| PHR | ▼ Sell | Open Market | 400 | $11K | 11/2/2022 | View on chart |
| PHR | ▼ Sell | Open Market | 9,955 | $270K | 11/2/2022 | View on chart |
| PHR | ▼ Sell | Open Market | 8,986 | $238K | 11/2/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 623 | $14K | 10/14/2022 | View on chart |
| PHR | ▲ Buy | Grant | 1,854 | — | 9/12/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 822 | $24K | 9/12/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 624 | $14K | 7/14/2022 | View on chart |
| PHR | ▲ Buy | Option Exercise | 20,000 | $17K | 7/7/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 412 | $11K | 4/14/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 783 | $22K | 4/13/2022 | View on chart |
| PHR | ▲ Buy | Grant | 2,669 | — | 4/13/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 501 | $18K | 1/17/2022 | View on chart |
| PHR | ▼ Sell | Tax Withholding | 2,364 | $84K | 1/15/2022 | View on chart |
| PHR | ▲ Buy | Grant | 22,503 | $0 | 1/14/2022 | View on chart |
| PHR | ▲ Buy | Option Exercise | 9,281 | $19K | 10/21/2020 | View on chart |
| PHR | ▼ Sell | Open Market | 10,834 | $379K | 10/21/2020 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Barclays Raises Phreesia Price Target to $11
Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.
Barclays Raises Phreesia Price Target to $11. Barclays has raised its price target for Phreesia to $11 while maintaining an Equal-Weight rating. This update places the firm's outlook within the broader analyst consensus, which currently averages $14.13. The stock remains well below its 52-week high of $24.07, reflecting a significant drop from previous levels.